7/23/2008
General News
|
"MedAssets' Supplier Recognition Program uses an objective and defined setof criteria to recognize what we consider as true leaders in the industry,providing superior services to our customer base," said Mary Ellen Kimmeth,Vice President, Laboratory and Capital Equipment Services, MedAssets SupplyChain Systems. "We are pleased to award a Platinum Vendor designation to IL,whose high quality analytical products and services, and the cost-efficienciesthey represent, are valued by our customers." "We are truly honored to be chosen as a Platinum Vendor by MedAssets,based on such criteria as value and customer satisfaction. This acknowledgesexactly what we strive to achieve every day," said Brian Durkin, Director ofSales and National Accounts at IL. "When customers find value andsatisfaction in our products, it translates to confidence in their testresults and more time to focus on what really matters: delivering qualitypatient care." IL and MedAssets currently hold a multi-year contract for IL's criticalcare portfolio, covering IL's critical care analyzers, including the GEMPremier 4000 and GEM Premier 3000, reagents, consumables and service. Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwidedeveloper, manufacturer and distributor of in vitro diagnostic instruments,related reagents and controls for use primarily in hospitals and independentclinical laboratories. The company's product lines include critical caresystems, hemostasis systems and information management systems. IL's GEMproduct offerings, part of the critical care line, include the new GEM Premier4000 analyzer with Intelligent Quality Management (iQM(R)), GEM Premier 3000analyzer, GEM OPL(TM), a portable whole blood CO-Oximeter and the GEM PCLPlus, a portable coagulation analyzer. IL's hemostasis portfolio includes theACL TOP(R) Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP and the new ACL TOP 500 CTS. ILalso offers the ACL ELITE(R) and ELITE PRO, other hemostasis analyzers and theHemosIL(R) line of reagents. IL is based in Lexington, Massachusetts. MedAssets (Nasdaq: MDAS) partners with healthcare providers to improvetheir financial strength by implementing integrated spend management andrevenue cycle solutions that help control cost, improve margins and cash flow,increase regulatory compliance, and optimize operational efficiency. MedAssetsserves more than 125 health systems, 3,300 hospitals and 30,000 non-acute carehealthcare providers. For more information, visit www.medassets.com. SOURCE Instrumentation Laboratory |
|
|
|
||